Chat
Human Immunodeficiency Virus 1 (HIV-1) by Qualitative Transcription-Mediated Amplification (TMA)
2014234
Copy Utility
Ordering Recommendation
Mnemonic
HIV-1 TMA
Methodology
Qualitative Transcription-Mediated Amplification
Performed
Varies
Reported
3-12 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Lavender (EDTA). Also acceptable: Yellow (ACD Solution A), Light Blue (Sodium Citrate), Plasma Preparation Tube (PPT), Plain Red, or Serum Separator Tube (SST).
Specimen Preparation
Separate from cells within 24 hours of collection. Transfer 1.6 mL plasma or serum to an ARUP Standard Transport Tube. (Min: 0.6 mL)
Storage/Transport Temperature
Frozen. Also acceptable: Refrigerated.
Unacceptable Conditions
Frozen plasma in Plasma Preparation Tube (PPT).
Remarks
Stability
Ambient: 72 hours; Refrigerated: 5 days; Frozen: 35 days
Reference Interval
By report
Interpretive Data
No compliance statements are in use for this test.
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
87535
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 2014235 | HIV-1 by Qualitative TMA | 25835-0 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
Human Immunodeficiency Virus 1 (HIV-1) by Qualitative Transcription-Mediated Amplification (TMA)
Quest Diagnostics Infectious Disease Inc.
Feedback
